|
Selected Articles |
STRATEGY
Drug Research and DevelopmentBridging the innovation gap
What needs to be done to improve or change the R&D productivity of the pharmaceutical industry? Is biotech consolidation the answer, and if not, what is?
Neil J Campbell
Chief Executive Officer, Mosaigen, Inc.
|
US Biotech and Indian Pharma Is there a win-win partnering strategy?
Due to emerging factors such as escalating financial risks, lack of new blockbuster drugs and evolving global capabilities, the time is right for US biotechnology firms and Indian pharmaceutical companies to join forces in the pre-commercial phases of drug research and development.
Vipin K Garg
President and Chief Executive Officer, Tranzyme Pharma
|
Volkmar Weissig
Gerard G M D'Souza
Sarathi V Boddapati
Associate Professor of Pharmacology, Midwestern University
Formulation Development Scientist, Northeastern University
Formulation Development Scientist, Novavax Inc
|
Multi-functional Nanomedicine Technology convergence in development of targeted therapeutics
The use of multi-functional nanosystems affords convergence of technologies for simultaneous or sequential target-specific delivery of multiple drugs or by combining drugs with different energy modalities.
Mansoor M Amji
Padmaja Magadala
Professor and Associate Department Chairman, Northeastern University
Department of Pharmaceutical Sciences, Northeastern University
|
Mark A Goldberg
President, PAREXEL International Corporation
|
Adaptive Trial Design Enhancing the quality of clinical trials
Adaptive / flexible trial design has begun to catch-up with the clinical trial services providers due to its umpteen benefits that go a long way in delivering better drugs in a much shorter time. This article looks at different types of adaptive designs available, their characteristics, infrastructure, and the associated legal aspects.
Mark Chang
Scientific Fellow, Millennium Pharmaceuticals Inc
|
INFORMATION TECHNOLOGY
Web 2.0 in Pharma Enterprise Improving internal communication
The adoption of simple and easy-to-use Web 2.0-inspired technologies and approaches inside the enterprise provides companies with opportunities to improve their collaboration, communication and knowledge sharing.
Simon Revell
Manager, Enterprise 2.0 Technology Development, Pfizer Inc
|
Chip Allee
Chief Executive Officer, CeuticalSoft Inc.
|
MANUFACTURING
Pharmaceutical Manufacturing Embracing process analytical technology
The idea behind Process Analytical Technology has been a proven technology in oil refineries, petrochemical, food & beverage and semiconductor industries. Pharmaceutical and Biotech companies can ensure improved quality, reduced scrap and enhanced productivity by learning from the experiences of these industries.
Pala Bushanam Janardhan
Business Consultant, Life Sciences and Healthcare Practice, HCL Technologies Ltd.
|
PAT and ROI A holistic approach
Despite the advantages PAT offers to the pharmaceutical industry, many companies remain hesitant about its implementation due to high investment costs.
Ingrid Maes
Consultant, Siemens AG
|
|
|
|
